Academic Staff
Degree | Department/Program | Institute | Year |
1989 | |||
1995 | |||
2000 | |||
2006 | |||
2012 |
1. ERİŞKİN AKUT LENFOBLASTİK LÖSEMİDE İNTENSİF MULTİ-AJAN KEMOTERAPİ SONUÇLARI, Supervisor: Dr. EKREM MÜFTÜOĞLU, Dicle University, Others, Basic Medical Sciences Department, DİYARBAKIR, Turkey, .
2. NÖTROPENİK HASTALARDA HEMATOPOETİK FAKTÖRLERİN YERİ, Supervisor: Dr. ZAHİT BOLAMAN, Dicle University, Others, Basic Medical Sciences Department, DİYARBAKIR, Turkey, .
Title | Institute | Year |
HEMATOLOJI BILIM DALI BASKANI | MERSIN UNIVERSITESI | 2008-04-13 - Continue |
Title | Dutie | Institution/Other | Year |
PROF.DR | HASTANE TRANSFUZYON KOMITESI | 2005-03-09 - Continue | |
PROFESOR DOKTOR | TRANSFUZYON MERKEZI MUDURU | 2002-06-01 - Continue | |
2013-04-03 - 2016-04-03 |
2021
45. KOYUNCU, M.; GÜLER, E.; KÖŞECİ, T.; UÇAR, M.; TOMBAK, A.; AKDENİZ, A.; TİFTİK, E.; ÇAVUŞOĞLU, Ç. . BIOMARKERS IN MEDICINE, 2021, , -. 160 + 0 10.2217/bmm-2021-0696
44. ALAKAYA, M.; KAYA, S.; ARSLANKÖYLÜ, A.; TEZOL, Ö.; KARHAN, A.; TİFTİK, E. . TURKISH JOURNAL OF PEDIATRIC DISEASE, 2021, 15, 294-298. 400 + 0 10.12956/tchd.715777
43. TİFTİK, E. . EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25, 6557-6565. 1000 + 0 10.26355/eurrev_202111_27126
42. TİFTİK, E. . CLINICAL LABORATORY, 2021, 67, 2700-2706. 1000 + 0 10.7754/Clin.Lab.2021.210324)
41. KOYUNCU, M.; KÖŞECİ, T.; GÜLER, E.; TEN, B.; APAYDIN, F.; NAYIR, E.; BASIR, H.; AKDENİZ, A.; TOMBAK, A.; TİFTİK, E. . TURKISH JOURNAL OF GERIATRICS, 2021, 24, 518-525. 100 + 0 10.31086/tjgeri.2021.249
40. ERAS, N.; TÜRKÖZ, G.; TOMBAK, A.; TİFTİK, E.; YALIN, S.; BERKÖZ, M.; AKBAŞ, E.; ERDEN, S. . ARCHIVES OF MEDICAL SCIENCE, 2021, 4, 928-933. 450 + 0 10.5114/aoms.2019.89692
39. SEZGİN, O.; YARAŞ, S.; TEZCAN ÜLGER, S.; ASLAN, G.; TİFTİK, E. . TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32, 782-789. 500 + 0 10.5152/tjg.2021.20870
2020
38. TİFTİK, E. . CLINICAL LABORATORY, 2020, 66, 1709-1715. 1000 + 0 10.7754/Clin.Lab.2020.191218.
2019
37. TİFTİK, E. . TRANSFUSION AND APHERESIS SCIENCE, 2019, 58, 659-662. 1000 + 0 10.1016/j.transci.2019.08.021
36. KOYUNCU, M.; Balık Aydın, B.; UÇAR, M.; AKDENİZ, A.; TOMBAK, A.; TİFTİK, R.; TÜRKEGÜN, M.; TİFTİK, E. . TUKISH JOURNAL OF HEMATOLOGY, 2019, 36, 47-82. 0 + 0
35. TİFTİK, E. . TURKISH JOURNAL OF HEMATOLOGY, 2019, 36, 230-237. 1000 + 0 10.4274/tjh
2018
34. Aydınok, Y.; Oymak, Y.; Atabay, B.; Aydoğan, G.; Yesilipek, A.; Ünal, S.; Kılınç, Y.; Oflaz, B.; Akın, M.; Vergin, C. A national registry of thalassemia in Turkey; demographic and disease characteristics of patients, achievements and challenges in prevention. TURKISH JOURNAL OF HEMATOLOGY, 2018, 35, 12-18. 0 + 0 http://dx.doi.org/10.4274/tjh.2017.0039
33. ÜN, İ.; BARLAS, İ.; UYAR, N.; TAŞDELEN, B.; TİFTİK, E. . TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2018, , -. 500 + 0
32. TİFTİK, E. . TURKISH JOURNAL OF HEMATOLOGY, 2018, 35, 12-18. 1000 + 0 10.4274/tjh.2017.0039
2017
31. Yavasoglu, I.; Sargin, G.; Yilmaz, F.; Altındag, S.; Akgun, G.; Tombak, A.; Toka, B.; Dal, S.; Ozbas, H.; Cetin, G. Cholesterol Levels in Patients with Chronic Lymphocytic Leukemia. ELSEVIER BV, 2017, 109, 23-27. 0 + 0 http://dx.doi.org/10.1016/j.jnma.2016.11.006 Publications_001.pdf
30. ERAS, N.; TOMBAK, A.; TİFTİK, E.; YALIN, S.; BERKÖZ, M.; KUL, S.; AKBAŞ, E.; TÜRKÖZ, G. . INTERNATIONAL JOURNAL OF HEMATOLOGY AND ONCOLOGY, 2017, 27, 21-28. 550 + 0 10.4999/uhod.171668
29. TOMBAK, A.; uçar, m.; AKDENİZ, A.; YILMAZ, İ.; KALEAĞASI, Ş.; SUNGUR, M.; TİFTİK, E. . INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33, 97-105. 200 + 0 10.1007/s12288-016-0661-3
28. Eras, N. Association Between PON1 L55M Polymorphism and PON1 Enzyme Activity in Patients with Leukemia.. AKADEMI DOKTORLAR YAYINEVI, 2017, 27, 21-28. 0 + 0 http://dx.doi.org/10.4999/uhod.171668
27. TİFTİK, E. . JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2017, 109, 23-27. 1000 + 0 10.1016/j.jnma.2016.11.006
2016
26. TOMBAK, A.; Uçar, M.; AKDENİZ, A.; TİFTİK, E.; GÖREN ŞAHİN, D.; AKAY, O.; YILDIRIM, M.; Nevruz, O. . TURKISH JOURNAL OF HEMATOLOGY, 2016, 33, 273-280. 450 + 0 10.4274/tjh.2015.0203
25. TİFTİK, E. . LEUKEMIA RESEARCH, 2016, , -. 1000 + 0
24. Karakaya, B.; Tombak, A.; Serin, M.; Tiftik, N. Change in plasma a disintegrin and metalloprotease with thrombospondin type-1 repeats-13 and von Willebrand factor levels in venous thromboembolic patients. INFORMA UK LIMITED, 2016, 21, 295-299. 0 + 0 http://dx.doi.org/10.1080/10245332.2015.1125079
23. Tombak, A.; Uçar, M.; Akdeniz, A.; Tiftik, E.; Gören Şahin, D.; Akay, O.; Yıldırım, M.; Nevruz, O.; Kış, C.; Gürkan, E. The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study. GALENOS YAYINEVI, 2016, 33, 273-280. 350 + 3 http://dx.doi.org/10.4274/tjh.2015.0203
22. şenol, p.; TİFTİK, E.; ÜNAL, S.; AKDENİZ, A.; TAŞDELEN, B.; TUNÇTAN, B. . QUALITY OF LIFE, CLINICAL EFFECTIVENESS, AND SATISFACTION IN PATIENTS WITH BETA THALASSEMIA MAJOR AND SICKLE CELL ANEMIA RECEIVING DEFERASIROX CHELATION THERAPY., 2016, , -. 750 + 0 10.4103/0976-0105.177706.
21. Salim, O.; Toptas, T.; Avsar, E.; Yucel, O.; Ozturk, E.; Ferhanoglu, B.; Geduk, A.; Mehtap, O.; Tombak, A.; Tiftik, E. Azacitidine versus decitabine in patients with refractory anemia with excess blast—Results of multicenter study. ELSEVIER BV, 2016, 45, 82-89. 100 + 10 http://dx.doi.org/10.1016/j.leukres.2016.04.003
Times Cited: 2
2015
20. Tombak, A.; Boztepe, B.; Tiftik, N.; Comert, M.; Salim, O.; Aydin, K.; Gurkan, E.; Yucel, O.; Saydam, G.; Sungur, M. Seasonal Association of Immune Thrombocytopenia in Adults. AVES PUBLISHING CO., 2015, 32, 347-351. 0 + 15 http://dx.doi.org/10.5152/balkanmedj.2015.151223
Times Cited: 3
19. Tombak, A.; Aygün, S.; Serinsöz, E.; Tiftik, E. Complete recovery of pyoderma gangrenosum after successful treatment of underlying hairy cell leukemia with cladribine. KOREAN ASSOCIATION OF INTERNAL MEDICINE, 2015, 30, 739-741. 650 + 5 http://dx.doi.org/10.3904/kjim.2015.30.5.739
Times Cited: 1
18. Tombak, A.; Ay, O.; Erdal, M.; Sungur, M.; Ucar, M.; Akdeniz, A.; Tiftik, E. MicroRNA Expression Analysis in Patients with Primary Myelofibrosis, Polycythemia vera and Essential Thrombocythemia. SPRINGER SCIENCE + BUSINESS MEDIA, 2015, 31, 416-425. 200 + 13 http://dx.doi.org/10.1007/s12288-014-0492-z
Times Cited: 2
2014
17. TURGUTALP, K.; ÖZHAN, O.; AKBAY, E.; TOMBAK, A.; TİFTİK, E.; ÖZCAN, T.; YILMAZ, S.; KIYKIM, A. . CLIN APPL THROMB HEMOST, 2014, 20, 190-195. 350 + 0 10.1177/1076029612456734
16. Giray, B.; Emekdas, G.; Tezcan, S.; Ulger, M.; Serin, M.; Sezgin, O.; Altintas, E.; Tiftik, E. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma. SPRINGER SCIENCE + BUSINESS MEDIA, 2014, 41, 4513-4519. 100 + 235 http://dx.doi.org/10.1007/s11033-014-3322-3
Times Cited: 42
2013
15. Korkmaz, S.; Keklik, M.; Sivgin, S.; Yildirim, R.; Tombak, A.; Kaya, M.; Acik, D.; Esen, R.; Hacioglu, S.; Tiftik, E. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study. ELSEVIER BV, 2013, 48, 353-358. 100 + 0 http://dx.doi.org/10.1016/j.transci.2013.04.016
2012
14. Turgutalp, K.; Ozhan, O.; Akbay, E.; Tombak, A.; Tiftik, N.; Ozcan, T.; Yilmaz, S.; Helvaci, I.; Kiykim, A. Mean Platelet Volume and Related Factors in Patients at Different Stages of Diabetic Nephropathy: A Preliminary Study. SAGE PUBLICATIONS, 2012, 20, 190-195. 0 + 10 http://dx.doi.org/10.1177/1076029612456734
Times Cited: 2
2009
13. YALCIN, A.; SERIN, M.; EMEKDAS, G.; TIFTIK, N.; ASLAN, G.; ESKANDARI, G.; TEZCAN, S. Promoter methylation of P15 INK4B gene is possibly associated with parvovirus B19 infection in adult acute leukemias . WILEY-BLACKWELL, 2009, 31, 407-419. 0 + 5 http://dx.doi.org/10.1111/j.1751-553X.2008.01052.x
Times Cited: 1
12. yalçın, a.; SERİN, M.; EMEKDAŞ, G.; TİFTİK, E.; ASLAN, G.; ESKANDARİ, H.; TEZCAN ÜLGER, S. . INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2009, 31, 407-419. 500 + 0 10.1111/j.1751-553X.2008.01052.x
11. Kiykim, A.; Genctoy, G.; Horoz, M.; Tiftik, N.; Gok, E.; Altun, B.; Arici, M.; Haznedaroglu, I. Serum Stem Cell Factor Level in Renal Transplant Recipients With Posttransplant Erythrocytosis. WILEY-BLACKWELL, 2009, 33, 1086-1090. 0 + 0 http://dx.doi.org/10.1111/j.1525-1594.2009.00823.x
2006
10. konca, k.; TİFTİK, E.; ASLAN, G.; KANIK, E.; yalçın, a. . TRANSFUSION AND APHERESIS SCIENCE, 2006, 34, 193-198. 800 + 0 10.1016/j.transci.2005.12.001[Indexed for MEDLINE]
9. Kalkanli, S.; Ayyildiz, O.; Tiftik, N.; Batun, S.; Isikdogan, A.; Ince, H.; Tekes, S.; Muftuoglu, E. Factor V Leiden Mutation in Venous Thrombosis in Southeast Turkey. SAGE PUBLICATIONS, 2006, 57, 193-196. 0 + 0 http://dx.doi.org/10.1177/000331970605700209
2004
8. Ayyildiz, O.; Kalkanli, S.; Batun, S.; Aybak, M.; Isikdogan, A.; Tiftik, N.; Bolaman, Z.; Soker, M.; Muftuoglu, E. Prothrombin G20210A gene mutation with LightCycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey. SPRINGER NATURE, 2004, 19, 0-0. 0 + 0 http://dx.doi.org/10.1007/s00380-003-0760-6
7. Tiftik, N.; Altinta?, E.; K?yk?m, A.; ��bilek, E.; Sezgin, O. Long-term red blood cell exchange can be used to successfully treat sickle cell intrahepatic cholestasis: A case report. WILEY-BLACKWELL, 2004, 19, 17-19. 0 + 0 http://dx.doi.org/10.1002/jca.10077
6. Hazar, B.; Polat, G.; Seyrek, E.; Baǧdatoǧlǧlu, Ö.; Kanik, A.; Tiftik, N. Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in Hodgkin's and non-Hodgkin's lymphoma. WILEY-BLACKWELL, 2004, 58, 139-143. 0 + 10 http://dx.doi.org/10.1111/j.1368-5031.2004.0023.x
Times Cited: 2
5. Isikdogan, A.; Ayyildiz, O.; Buyukcelik, A.; Arslan, A.; Tiftik, N.; Buyukbayram, H.; Muftuoglu, E. Non-Hodgkin?s lymphoma in southeast Turkey: clinicopathologic features of 490 cases. SPRINGER SCIENCE + BUSINESS MEDIA, 2004, 83, 265-269. 0 + 5 http://dx.doi.org/10.1007/s00277-003-0812-0
Times Cited: 1
4. Kiykim, A.; Ozer, C.; Yildiz, A.; Tiftik, N.; Senli, M.; Kelebek, E.; Doruk, E.; Akbay, E. Development of transplant renal artery thrombosis and signs of haemolytic-uraemic syndrome following the change from cyclosporin to tacrolimus in a renal transplant patient. OXFORD UNIVERSITY PRESS (OUP), 2004, 19, 2653-2656. 0 + 0 http://dx.doi.org/10.1093/ndt/gfh375
3. TİFTİK, E.; BOLAMAN, A.; BATUN, M.; AYYILDIZ, M.; IŞIKDOĞAN, A.; GÜRHAN, K.; MÜFTÜOĞLU, E. . INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58, 149-152. 800 + 0
2003
2. Isikdogan, A.; Ayyildiz, O.; Dursun, M.; Tiftik, N.; Batun, S.; Muftuoglu, E. Hepatitis C Virus in Patients with Non-Hodgkin's Lymphoma in Southeastern Anatolia Region of Turkey: A Prospective Case-control Study of 119 Patients. INFORMA UK LIMITED, 2003, 44, 1745-1747. 0 + 0 http://dx.doi.org/10.1080/1042819031000116724
1. TİFTİK, E.; KIYKIM, A.; ALTINTAŞ, E.; SEZER, K.; DORUK, N.; SEZGİN, O.; seyrek, e.; BÜYÜKAFŞAR, K.; oral, u. . JOURNAL OF CLINICAL APHERESIS, 2003, 18, 132-133. 0 + 0
2016
10. Tunctan, B.; Senol, S.; Tiftik, E.; Unal, S.; Akdeniz, A.; Tasdelen, B. Quality of life, clinical effectiveness, and satisfaction in patients with beta thalassemia major and sickle cell anemia receiving deferasirox chelation therapy. MEDKNOW, 2016, 7, 49-49. 130 + 0 http://dx.doi.org/10.4103/0976-0105.177706
2014
9. Oksuz, Z.; Serin, M.; Kaplan, E.; Dogen, A.; Tezcan, S.; Aslan, G.; Emekdas, G.; Sezgin, O.; Altintas, E.; Tiftik, E. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. SPRINGER SCIENCE + BUSINESS MEDIA, 2014, 42, 713-720. 20 + 148 http://dx.doi.org/10.1007/s11033-014-3819-9
2011
8. Şahin, E.; Ersöz, G.; Tombak, A.; Tiftik, N.; Kaya, A. Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients. MEDICAL SCIENCE MONITOR, 2011, 17, 304-309. 0 + 0
2006
7. KAYA, T.; TİFTİK, E.; TÜRSEN, Ü.; İKİZOĞLU, G.; YALÇIN, A. Ultraviolet recall phenomenon associated with methotrexate and cytarabine. J EUR ACAD DERMATOL VENEREOL., 2006, 20, 353-354. 80 + 0
2005
6. Yazar, A.; Büyükafşar, K.; Polat, G.; Pata, C.; Kanık, A.; Tiftik, E.; Bağdatoğlu, Ö. The urinary 5-hydroxyindole acetic acid and plasma nitric oxide levels in irritable bowel syndrome: a preliminary study.. SCOTT MED J, 2005, 50, 27-29. 60 + 0
5. TÜRSEN, Ü.; TİFTİK, E.; ÜNAL, Ş.; GÜNDÜZ, Ö.; KAYA, T.; ÇAMDEVİREN, H.; İKİZOĞLU, G. Relationship between ABO blood groups and skin cancers.. DERMATOL ONLINE J., 2005, 11, 44-44. 140 + 0
2004
4. Baz, K. Fatal aplastic anaemia in a patient with clarithromycin-induced toxic epidermal necrolysis. J EUR ACAD DERMATOL VENEREO, 2004, 18, 104-105. 0 + 0
2003
3. Altıntaş, E. Sickle cell anemia connected with chronic intrahepatic cholestasis: a case report. TURK J GASTROENTEROL, 2003, 14, 215-218. 0 + 0
2. Kıykım, A. Valsartan-induced hepatotoxicity in a HBs-Ag-Positive patient. AM J GASTROENTEROL, 2003, 98, 507-507. 0 + 0
1. Pata, C. Serum levels of intercellular adhesion molecule-1 and nitric oxide in patients with chronic hepatitis related to hepatitis C virus: connection fibrosis. HEPATOGASTROENTEROLOGY, 2003, 50, 794-797. 0 + 0
2022
6. KOYUNCU, M.; İLĞAN, M.; BASIR, H.; TOMBAK, A.; UÇAR, M.; KÖŞECİ, T.; AKDENİZ, A.; TİFTİK, E.; EREL, Ö. . CUREUS, 2022, , -. 10 + 0 10.7759/cureus.20929
5. ÜLGER, M.; SERİN, M.; TEZCAN ÜLGER, S.; ASLAN, G.; İLVAN, A.; TİFTİK, E.; EMEKDAŞ, G. . THE JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (JIDC), 2022, 16, 1166-1173. 30 + 0 10.3855/jidc.15831
2021
4. KOYUNCU, M.; TOMBAK, A.; ÖRSÇELİK, Ö.; KÖŞECİ, T.; TÜRKER, A.; BASIR, H.; AKDENİZ, A.; TİFTİK, E. . CUREUS, 2021, , -. 10 + 0 10.7759/cureus.15592
3. KOYUNCU, M.; BASIR, H.; İLĞAN, M.; UÇAR, M.; AKDENİZ, A.; TOMBAK, A.; NEŞELİOĞLU, S.; TİFTİK, E. . DUZCE MED J, 2021, 23, 137-141. 10 + 0 10.18678/dtfd.890142
2. KOYUNCU, M.; ÇAVUŞOĞLU, Ç.; TOMBAK, A.; UÇAR, M.; AKDENİZ, A.; TİFTİK, E. . CUKUROVA MEDICAL JOURNAL, 2021, 46, 1574-1580. 40 + 0 10.17826/cumj.977316
1. EROĞLU KÜÇÜKDİLER, A.; YAVAŞOĞLU, İ.; SELİM, C.; ATMACA MUTLU, C.; KARAKUŞ, A.; KOYUNCU, M.; BİLGİR, O.; AYYILDIZ, M.; TİFTİK, E.; BOLAMAN, A. . LEUKEMIA RESEARCH REPORTS, 2021, 17, 100280-. 10 + 0 10.1016/j.lrr.2021.100280.
2020
4. BAYRAM ABİHA, G.; DİNÇER, E.; ERDEN, S.; TİFTİK, E. . FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2020, 25, 33-39. 65 + 0 10.5578/flora.68443
3. BAKIR, M.; ATICI, Ş.; YILDIRIM, H.; TİFTİK, E.; ÜNAL, S. . AGRI DERGISI, 2020, 32, 115-119. 60 + 0 10.14744/agri.2020.46354
2. AKDENİZ, A.; OREKİCİ TEMEL, G.; BALIK AYDIN, B.; KOYUNCU, M.; UÇAR, M.; TOMBAK, A.; TİFTİK, R.; TİFTİK, E. . ANNALS OF MEDICAL RESEARCH, 2020, 27, 3071-3075. 10 + 0 10.5455/annalsmedres.2020.03.250
2018
1. BAYRAM ABİHA, G.; DİNÇER, E.; ERDEN, S.; TİFTİK, E. . KASMERA JOURNAL, 2018, 46, 2-13. 65 + 0
2022
9. KOYUNCU, M.; TOMBAK, A.; KÖŞECİ, T.; TÜRKER, A.; BASIR, H.; İLĞAN, M.; AKDENİZ, A.; TİFTİK, E.; EREL, Ö. . MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI, 2022, 15, 1-7. 20 + 0 10.26559/mersinsbd.951589
8. KOYUNCU, M.; TOMBAK, A.; KÖŞECİ, T.; TÜRKER, A.; BASIR, H.; İLĞAN, M.; AKDENİZ, A.; TİFTİK, E.; EREL, Ö. . MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGIS, 2022, 15, 1-7. 20 + 0
2020
7. GÜVEN, O.; GÜR, H.; BOZDOĞAN ARPACI, R.; TİFTİK, E.; İSMİ, O. . ENTCASE, 2020, 6, 87-92. 0 + 0
2016
6. Akdeniz, A.; Tiftik, E. Geleneksel ve Yeni Parenteral Antikoagülanlar. TURKIYE KLINIKLERI HEMATOLOJI OZEL DERGISI, 2016, 9, 49-55. 200 + 0
5. Tiftik, E.; Koyuncu, M. Emergency Transfusion and Massive Transfusion. TURKIYE KLINIKLERI HEMATOLOJI OZEL DERGISI, 2016, 9, 125-128. 200 + 0
2015
4. Tombak, A.; Görür, A.; Balcı, Ş.; Tiftik, N.; Tamer, L. Circulating MicroRNAs in Newly Diagnosed Acute and Chronic Leukemias. ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2015, 25, 75-80. 0 + 0
2013
3. Tombak, A. Cardiac Tamponade: An Unusual Presentation of Multiple Myeloma: Case Report. TURKIYE KLINIKLERI JOURNAL OF CASE REPORTS, 2013, 21, 167-170. 0 + 0
2006
2. TİFTİK, E. . INFEKSIYON DERGISI (TURKISH JOURNAL OF INFECTION), 2006, 20, 41-55. 200 + 0
1. ŞAHİN, E.; ERSÖZ, G.; OTAĞ, F.; KANDEMİR, Ö.; TİFTİK, E.; KAYA, A.; YALÇIN, A. HEMATOLOJİK MALİGNİTELİ NÖTROPENİK ATEŞLİ HASTALARDAN İZOLE EDİLEN CANDIDA TÜRLERININ DEĞERLENDİRİLMESİ. INFEKSIYON DERGISI, 2006, 20, 121-124. 80 + 0
1. KANDEMİR, F.; ŞAHİN HORASAN, E.; TİFTİK, E.; KAYA, A. . ANKEM DERG, 2006, 20, 98-102. 0 + 0
2014
4. Tombak, A. Chronic Lymphocytic Leukemia With Meningeal Infiltration By Monoclonal T Lymphocytes. CAUSAPEDIA HAKEMLI OLGU DERGISI, 2014, 3, 926-927. 0 + 0
3. Tezcan, S. Flavivirus Seroepidemiology in Blood Donors in Mersin Province, Turkey. MIKROBIYOLOJI BULTENI, 2014, 48, 606-617. 0 + 0
2006
2. ŞAHİN HORASAN, E.; ERSÖZ, G.; OTAĞ, Z.; KANDEMİR, F.; TİFTİK, E.; KAYA, A.; yalçın, a. . TURKISH JOURNAL OF INFECTION, 2006, 20, 121-124. 40 + 0
1. SERİN, M.; TEZCAN ÜLGER, S.; DELİALİOĞLU, N.; TİFTİK, E.; ASLAN, G.; EMEKDAŞ, G. . MIKROBIYOLOJI BULTENI, 2006, 40, 39-45. 55 + 0
1. TİFTİK, E. . TURK J INFECT, 2006, 20, 41-55. 100 + 0
2016
2. TİFTİK, E.; KOYUNCU, M. . TURKIYE KLINIKLERI HEMATOLOJI - OZEL KONULAR, 2016, 9, 125-128. 100 + 0
2013
1. TİFTİK, E.; TOMBAK, A. . TURKIYE KLINIKLERI JOURNAL OF HEMATOLOGY SPECIAL TOPICS, 2013, 6, 79-85. 100 + 0
1. TİFTİK, E.; KOYUNCU, M. Targeted therapy in cancer, ISBN: 978-625-6598-21-8, Orient Publications, Number of print: 1, Total Printing Number: , 90 Page, English, Ankara, Turkey, 2023. 0
1. Tiftik, E. TÜRK HEMATOLOJİ DERNEĞİ, HEMATOLOG, KAN BANKACILIĞI, TRANSFÜZYON TIBBI VE AFEREZ, ISBN: ISSN: 2146-6408, Galenos yayınevi, Number of print: 1, Total Printing Number: 100, 6 Page, Turkish, İstanbul, Turkey, 2015. 250
1. Soysal, T.; Bayık, M.; Demir, M.; Tiftik, E. TÜRK HEMATOLOJİ DERNEĞİ, HEMATOLOG, KAN BANKACILIĞI, TRANSFÜZYON TIBBI VE AFEREZ, ISBN: ISSN: 2146-6408, Galenos yayınevi, Number of print: 1, Total Printing Number: 100, 359 Page, Turkish, İstanbul, Turkey, 2015. 63
1. ÜNAL, S.; SAYINALP, N.; AYDINOK, Y.; YAMAN BAJİN, H.; ÜNAL CANGÜL, Ş.; GÜMRÜK, F.; KUŞKONMAZ, B.; TİFTİK, E. Talsemi Hasta Kılavuzu, ISBN: , THD, Number of print: 1, Total Printing Number: , 66 Page, Turkish, Ankara, Turkey, 2017. 0
2. AYDINOK, Y.; TİFTİK, E.; ANDIÇ, N.; SEZGİN EVİM, M.; YILMAZ, A.; EKER, İ.; ÖZDOĞU, H.; BOĞA, C. Transfüzyon Tıbbı ve Kan Bankacılığı, ISBN: 978-605-82140-4-0, Galenos Yayınevi, Number of print: 1, Total Printing Number: , 63 Page, Turkish, İstanbul, Turkey, 2017. 0
1. BÜYÜKKURT, N.; TİFTİK, E. Türkiye Klinikleri Hematoloji Özel KonuOrak Hücre Hastalığı, ISBN: 9786050340419, Türkiye Klinikleri (Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.), Number of print: 1, Total Printing Number: , Page, Turkish, , Turkey, 2019. 0
2. TİFTİK, E. Transfüzyon Tıbbı ve Kan Bankacılığı Kılavuzu, ISBN: 978-605-821140-4-0, Galenos, Number of print: 1, Total Printing Number: , Page, Turkish, , Turkey, 2017. 0
2. TİFTİK, E., diğer. EHA Kongresi, 2018-06-14, 2018-06-17, stockholm, Sweden, 2018. 50
http://eha.org
1. TİFTİK, E., 11th IHEM (International Hematology Expert Meeting). 11th IHEM (International Hematology Expert Meeting), 2018-04-26, 2018-04-28, viyana, Austria, 2018. 50
http://aoporphan.com
1. TİFTİK, E., Hemovigilans ile ilgili Temel Kavramlar ve Yasal Mevzuat. 2. Transfüzyon tıbbı ve kan bankacılığı sempozyumu, 2015-11-05, 2015-11-07, İstanbul, Turkey, 2015. 100
http://www.aferez2015.org
1. TİFTİK, E., Transfüzyon Güvenliği. Ulusal Hematoloji Kongresi, 2015-10-21, 2015-10-24, Antalya, Turkey, 2015. 50
http://thd.org.tr
10. TİFTİK, E., diğer. Uluslararası Kan Güvenliği ve Hemovijilans Kongresi, 2019-11-04, 2019-11-05, Antalya, Turkey, 2019. 25
http://kizilay.org.tr
9. TİFTİK, E., diğer. Ulusal Hematoloji Kongresi, 2019-10-30, 2019-11-01, Antalya, Turkey, 2019. 25
http://thd.org.tr
8. TİFTİK, E., diğer. “Türkiye’de Kan Transfüzyon Yönetim Sisteminin Geliştirilmesi için Teknik Yardım Projesi, 2019-06-14, 2019-06-14, Ankara, Turkey, 2019. 25
http://saglik.gov.tr
7. TİFTİK, E., diğer. 7. ICLLM Kongresi, 2019-05-02, 2019-05-04, İstanbul, Turkey, 2019. 25
http://icllm2019.org
6. TİFTİK, E., Diğer. 11. KİT Kongresi, 2019-02-28, 2019-03-01, Antalya, Turkey, 2019. 25
http://www.thdkitht2019.org/
5. TİFTİK, E., Diğer. 11. KİT Kongresi, 2019-02-28, 2019-03-01, Antalya, Turkey, 2019. 25
http://www.thdkitht2019.org/
4. TİFTİK, E., sayman. Ulusal Hemotoloji Kongresi, 2018-10-30, 2018-11-03, Antalya, Turkey, 2018. 25
http://thd.org.tr
3. TİFTİK, E., THD Yönetim Kurulu Üyesi. 10. Ulusal Kemik İliği Transplantasyon ve Hücresel Tedaviler Kongresi, 2018-02-27, 2018-03-02, Antalya, Turkey, 2018. 25
http://thd@org.tr
2. TİFTİK, E., Sayman. Ulusal Hematoloji Kongresi, 2017-10-31, 2017-11-05, Antalya, Turkey, 2017. 25
http://ulusalhematoloji2017.org
1. TİFTİK, E., Ulusal Hematoloji Kongresi Sayman olarak. 42. Ulusal Hematoloji Kongresi, 2016-10-18, 2016-10-22, Antalya, Turkey, 2016. 25
http://www.thd.org.tr
2. Determining the Efficacy of Different Types and Subtypes of Immune System Cells as Personalized Cancer Immunotherapy Agents by Utilizing from In Vitro and Ex Vivo Methods, BAP, Project Number: 2021-1-AP5-4286, 430000 TL, Manager, Continue... 100
1. AKUT TRANSFÜZYON REAKSİYONU ANALİZ VE TRANSFÜZYON HEMŞİRELİĞİ MODEL PROJESİ, TÜRK HEMATOLOJİ DERNEĞİ, Project Number: 2015,001, 30 TL, Manager, 2017,Completed. 0
3. , projects.kurumlar.14, Project Number: , TL, Researcher, 2018,Completed. 0
2. Evaluation of Transfusion-transmitted Parasites Epidemiology by Molecular and Serological Methods, BAP, Project Number: 2016-2-AP4-1923, 12496 TL, Researcher, 2018,Completed. 50
1. , projects.kurumlar.16, Project Number: , EUR, Researcher, 2017,Completed. 0
6. ENVER ÜÇBİLEK, KRONİK LÖSEMİLERDE DNA ONARIM GENİ XRCC1 Arg399Gln POLİMORFİZMİ SIKLIĞI, Others, Mersin University, Completed. 400
5. ANIL TOMBAK, PRİMER MİYELOFİBROZİS, POLİSTEMİA VERA VE ESANSİYEL TROMBOSİTEMİ HASTALARINDA MikroRNA EKSPRESYON ANALİZİ, Others, Mersin University, Completed. 400
4. EMRE YENGEL, ORAK HÜCRELİ ANEMİ HASTALARINDA AĞRILI KRİZ VE AĞRILI KRİZ OLMAYAN DÖNEMDE ADAMTS 13 AKTİVİTESİNDE MEYDANA GELEN DEĞİŞİKLİKLER, Others, Mersin University, Completed. 400
3. BÜLENT KARAKAYA, VENÖZ TROMBOEMBOLİLİ HASTALARDA PLAZMA ADAMTS 13 DÜZEYİNDE MEYDANA GELEN DEĞİŞİKLİKLER, Others, Mersin University, Completed. 400
2. ERDİNÇ EREN, KRONİK MİYELOİD LÖSEMİLİ HASTALARDA SAĞKALIM ANALİZİ VE PROGNOSTİK FAKTÖRLERİN RETROSPEKTİF OLARAK DEĞERLENDİRİLMESİ, Others, Mersin University, Completed. 400
1. AYŞEGÜL ÖZDOĞAN BİRCAN, RETROSPECTIVE INVESTIGATION AND ANALYSIS OF MULTİPLE MYELOM PATİENTS, Others, Mersin University, Completed. 400
1. GALENOS, TURKISH JOURNAL OF HEMATOLOGY , PUBLICATION BOARD MEMBER, E-ISSN : 1300-7777, 2015-11-30 - Continue. 500
1. TURKIYE KLINIKLERI HEMATOLOJI OZEL SAYISI TRANSFUZYON OZEL SAYISI , EDITOR, ISSN : 1308-1160, E-ISSN : 1308-1160, 2017-12-27 - Continue. 1000
1. TURKISH JOURNAL OF HEMATOLOGY , [ 2015 : 1 ] . 5
2. TURKISH JOURNAL OF HEMATOLOGY , [ 2016 : 1 ] . 5
3. TURKISH JOURNAL OF HEMATOLOGY , [ 2017 : 4 ] . 20
1. TURKISH JOURNAL OF HEMATOLOGY , [ 2018 : 4 ] . 4
1. 6. ULUSAL HÜCRESEL TEDAVİ VE REJENERATİF TIP KONGRESİ , Sekreter, 2 salon, MERKÖK, 2016-02-26-2016-02-28, 48 saat, Mersin, Turkey
1. , , , Turkey. 0
1. Türk Hematoloji Derneği , Member No: 414, Turkey, 2000-10-15-Continue.